Akouos Inc., a Wholly Owned Subsidiary of Eli Lilly and Company

We are a precision genetic medicine company focused on developing gene therapies with the potential to restore, improve, and preserve high-acuity physiologic hearing for people worldwide who live with disabling hearing loss.